Streptococcus agalactiae (group B) endocarditis--a description of twelve cases and review of the literature

Related Experiment Videos

Insights

Group B Streptococcus can cause serious endocarditis, particularly in patients with diabetes or cancer. Prompt medical and surgical intervention is crucial for managing this severe heart valve infection.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Group B Streptococcus (GBS) is a known cause of neonatal meningitis, sepsis, and postpartum infections.
  • GBS endocarditis is infrequently recognized, despite its potential severity.

Observation:

  • A retrospective review identified 12 cases of GBS endocarditis between 1974 and 1985.
  • Patients often had significant comorbidities, including diabetes mellitus, carcinoma, and alcoholism.
  • The aortic and tricuspid valves were most commonly affected.

Findings:

  • GBS endocarditis presented acutely in most cases, with high rates of metastatic infection, heart failure, and embolic events.
  • Despite GBS's usual susceptibility to penicillin, rapid valve destruction necessitates consideration of surgical intervention.
  • Underlying host defense defects, such as diabetes, cancer, and alcoholism, are key risk factors.

Implications:

  • Clinicians should consider GBS as a potential cause of acute bacterial endocarditis, especially in immunocompromised patients.
  • Early diagnosis and aggressive management, potentially including cardiac surgery, are vital for improving outcomes in GBS endocarditis.
  • Further research into GBS pathogenesis and treatment strategies for endocarditis is warranted.

Related Concept Videos